Vascular Access Devices Market Size, Share & COVID-19 Impact Analysis | United States | 2023-2029 | MedSuite | Includes: Implantable Ports, Port Needles, Central Venous Catheters, and 12 more
- Year: 2023
- Scope: 10 Years
- Region: United States
- Pages: 666
- Published Date: 03/07/2023
- Type: MedSuite
Overall, the U.S. vascular access device and accessories market was valued at $5.2 billion in 2022. This is expected to increase over the forecast period at a CAGR of 2.5% to reach $6.2 billion.
The full report suite on the U.S. market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), midlines, extended dwell catheters (EDCs), dialysis catheters, ultrasound machines specialized for vascular access, vein visualization devices, tip-placement devices, catheter securement devices, antibacterial catheter patches, catheter caps and syringes and needles.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Vascular Access Procedure Volumes
- Market Forecasts Until 2029, and Historical Data to 2019
- Competitive Analysis with Market Shares for Each Segment
- Market Drivers & Limiters for Each Vascular Access Device market
- Recent Mergers & Acquisitions
- COVID19 Impact on the US Vascular Access and Accessories market
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios, and SWOT for Top Competitors
U.S. Vascular Access Market Insights
Due to the complications and concerns associated with PICCs, the market has been shifting towards less expensive catheter devices with lower failure rates. Two popular alternatives gaining traction are midlines and extended dwell catheters, which are shorter and can be placed in peripheral veins to reduce the risk of infection and complications. New technologies have emerged to improve the dwell time and reduce failure rates of PIVCs, which can result in fewer catheters being required per patient. These advancements include antimicrobial coatings, better catheter materials, and improved insertion techniques.
U.S. Vascular Access Market Share Insight
Currently, the U.S. vascular access device market is controlled by Becton Dickinson, 3M, and Teleflex.
Due to the complications and concerns associated with PICCs, the market has been shifting towards less expensive catheter devices with lower failure rates. Two popular alternatives gaining traction are midlines and extended dwell catheters, which are shorter and can be placed in peripheral veins to reduce the risk of infection and complications. New technologies have emerged to improve the dwell time and reduce failure rates of PIVCs, which can result in fewer catheters being required per patient. These advancements include antimicrobial coatings, better catheter materials, and improved insertion techniques.
Market Segmentation Summary
- Implantable Port Market – MedCore
- Port Needle Market – MedCore
- Central Venous Catheter Market – MedCore
- Peripherally Inserted Central Catheter Market – MedCore
- Peripheral Intravenous Catheter Market – MedCore
- Midline Market – MedCore
- Extended Dwell Catheter Market – MedCore
- Dialysis Catheter Market – MedCore
- Vascular Access Ultrasound Market – MedCore
- Vein Visualization Device Market – MedCore
- Tip-placement Device Market – MedCore
- Catheter Securement Device Market – MedCore
- Antibacterial Catheter Patch Market – MedCore
- Catheter Cap Market – MedCore
- Syringe and Needle Market – MedCore
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (United States) |
| Base Year | 2022 |
| Forecast Period | 2023-2029 |
| Historical Data | 2019-2022 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Table of Contents
| TABLE of CONTENTS |
| List of Figures |
| List of Charts |
| executive summary |
| U.S. Vascular Access Devices and Accessories Market Overview |
| Competitive Analysis |
| Market Trends |
| Market Developments |
| Procedure Numbers |
| Procedure Codes Investigated |
| Markets Included |
| Key Report Updates |
| Version History |
| research methodology |
| Step 1: Project Initiation & Team Selection |
| Step 2: Prepare Data Systems and Perform Secondary Research |
| Step 3: Preparation for Interviews & Questionnaire Design |
| Step 4: Performing Primary Research |
| Step 5: Research Analysis: Establishing Baseline Estimates |
| Step 6: Market Forecast and Analysis |
| Step 7: Identify Strategic Opportunities |
| Step 8: Final Review and Market Release |
| Step 9: Customer Feedback and Market Monitoring |
| impact of covid-19 on THE U.S. Vascular Access Devices and Accessories Market |
| 2.1 Introduction |
| 2.2 Analysis By Market Segment |
| 2.2.1 Worst Case Scenario |
| 2.2.2 Base Case Scenario |
| 2.2.3 Best Case Scenario |
| Disease Overview |
| 3.1 Basic Anatomy |
| 3.1.1 Human Vascular System |
| 3.2 Disease Treatments & Diagnostics |
| 3.2.1 Cancer |
| 3.2.2 End-Stage Renal Disease |
| 3.2.3 Diabetes |
| 3.3 Patient Demographics |
| 3.3.1 Cancer |
| 3.3.1.1 Breast Cancer |
| 3.3.1.2 Colon and Rectum |
| 3.3.1.3 Kidney and Renal Pelvis |
| 3.3.1.4 Leukemia |
| 3.3.1.5 Liver |
| 3.3.1.6 Lungs and Bronchus |
| 3.3.1.7 Lymphoma |
| 3.3.1.8 Oral Cavity and Pharynx |
| 3.3.1.9 Ovary |
| 3.3.1.10 Pancreas |
| 3.3.1.11 Prostate |
| 3.3.1.12 Skin |
| 3.3.2 End-Stage Renal Disease |
| 3.3.3 Diabetes |
| Product Assessment |
| 4.1 Introduction |
| 4.2 Product Portfolios |
| 4.2.1 Implantable Ports |
| 4.2.2 Port Needles |
| 4.2.3 Central Venous Catheters |
| 4.2.4 Peripherally Inserted Central Catheters |
| 4.2.5 Peripheral Intravenous Catheters |
| 4.2.6 Midlines |
| 4.2.7 Extended Dwell Catheter Market |
| 4.2.8 Dialysis Catheters |
| 4.2.9 Ultrasound Vascular Access Devices and Accessories |
| 4.2.10 Vein Visualization Technology |
| 4.2.11 Tip-Placement System and Accessories |
| 4.2.12 Catheter Securement |
| 4.2.13 Antibacterial Catheter Patch |
| 4.2.14 Catheter Cap |
| 4.2.15 Syringes and Needles |
| 4.3 Regulatory Issues and Recalls |
| 4.3.1 Implantable Ports |
| 4.3.2 Port Needles |
| 4.3.3 Central Venous Catheters |
| 4.3.4 Peripherally Inserted Central Catheters |
| 4.3.5 Peripheral Intravenous Catheters |
| 4.3.6 Midlines |
| 4.3.7 Extended Dwell Catheter |
| 4.3.8 Dialysis Catheters |
| 4.3.9 Ultrasound Vascular Access Devices and Accessories |
| 4.3.10 Tip-Placement System |
| 4.3.11 Catheter Securement |
| 4.3.12 Syringes & Needles |
| 4.4 Clinical Trials |
| 4.4.1 Implantable Port |
| 4.4.2 Central Venous Catheters |
| 4.4.3 Peripherally Inserted Central Catheters |
| 4.4.4 Peripheral Intravenous Catheters |
| 4.4.5 Midlines |
| 4.4.6 Dialysis Catheter |
| 4.4.7 Ultrasound Vascular Access |
| 4.4.8 Vein Visualization Technology |
| 4.4.9 Catheter Securement |
| U.S. Vascular Access Devices and Accessories Market Overview |
| 5.1 Introduction |
| 5.2 Market Overview & Trend Analysis |
| 5.3 Drivers and Limiters |
| 5.3.1 Market Drivers |
| 5.3.2 Market Limiters |
| 5.4 Competitive Market Share Analysis |
| 5.5 Mergers and Acquisitions |
| 5.6 Company Profiles |
| 5.6.1 3M |
| 5.6.2 AccuVein |
| 5.6.3 AngioDynamics |
| 5.6.4 B. Braun |
| 5.6.5 Becton Dickinson |
| 5.6.6 Cardinal Health |
| 5.6.7 FUJIFILM SonoSite |
| 5.6.8 GE Healthcare |
| 5.6.9 ICU Medical |
| 5.6.10 Johnson & Johnson |
| 5.6.11 Medcomp |
| 5.6.12 Novo Nordisk |
| 5.6.13 Teleflex Medical |
| 5.7 SWOT Analysis |
| 5.7.1 3M |
| 5.7.2 AccuVein |
| 5.7.3 AngioDynamics |
| 5.7.4 B. Braun |
| 5.7.5 Becton Dickinson |
| 5.7.6 Cardinal Health |
| 5.7.7 FUJIFILM SonoSite |
| 5.7.8 GE Healthcare |
| 5.7.9 ICU Medical |
| 5.7.10 Johnson & Johnson |
| 5.7.11 Medcomp |
| 5.7.12 Novo Nordisk |
| 5.7.13 Teleflex Medical |
| Procedure Numbers |
| 6.1 Introduction |
| 6.2 Procedures |
| 6.2.1 Implantable Port Insertion Procedures |
| 6.2.1.1 Implantable Port Insertion Procedures by Material |
| 6.2.1.2 Implantable Port Insertion Procedures by Valve Type |
| 6.2.1.3 Implantable Port Insertion Procedures by Power-Injectability |
| 6.2.1.4 Implantable Port Insertion Procedures by Location |
| 6.2.1.5 Implantable Port Insertion Procedures by Setting |
| 6.2.1.6 Implantable Port Insertion Procedures by Patient Age Group |
| 6.2.1.7 Implantable Port Insertion Procedures by Operator |
| 6.2.2 Port Needle Insertion Procedures |
| 6.2.2.1 Port Needle Insertion Procedures by Setting |
| 6.2.3 Central Venous Catheter Procedures |
| 6.2.3.1 Central Venous Catheter Insertion Procedures by Device Type |
| 6.2.3.2 Central Venous Catheter Insertion Procedures by Insertion Site |
| 6.2.3.3 Central Venous Catheter Insertion Procedures by Imaging Technique |
| 6.2.3.4 Central Venous Catheter Insertion Procedures by Patient Type |
| 6.2.4 Peripherally Inserted Central Catheter Procedures |
| 6.2.4.1 Peripherally Inserted Central Catheter Insertion Procedures by Power-Injectability |
| 6.2.4.2 Peripherally Inserted Central Catheter Insertion Procedures by Patient Age Group |
| 6.2.4.3 Peripherally Inserted Central Catheter Insertion Procedures by Operator |
| 6.2.4.4 Peripherally Inserted Central Catheter Insertion Procedures by Setting |
| 6.2.5 Peripheral Intravenous Catheter Procedures |
| 6.2.5.1 Peripheral Intravenous Catheter Insertion Procedures by Setting |
| 6.2.5.2 Peripheral Intravenous Catheter Insertion Procedures by Device Type |
| 6.2.5.3 Peripheral Intravenous Catheter Insertion Procedures by Insertion Site |
| 6.2.5.4 Peripheral Intravenous Catheter Insertion Procedures by Visualization Method |
| 6.2.6 Midline Placement Procedures |
| 6.2.6.1 Midline Placement Procedures by Device Type |
| 6.2.6.2 Midline Placement Procedures by Power-Injectability |
| 6.2.7 Extended Dwell Placement Procedures |
| 6.2.8 Dialysis Catheter Placement Procedures |
| 6.2.8.1 Dialysis Catheter Placement Procedures by Device Type |
| 6.2.9 Vascular Access Ultrasound Procedures |
| 6.2.9.1 Vascular Access Ultrasound Procedures by Catheter Type |
| 6.2.9.2 Vascular Access Catheters Placed Using Ultrasound Guidance by Operator |
| 6.2.10 Vein Visualization Procedures |
| 6.2.11 Tip-Placement Device Procedures |
| 6.2.11.1 Tip-Placement Device Procedures by Catheter Type |
| 6.2.11.2 Tip-Placement Device Procedures by Operator |
| Implantable Port Market |
| 7.1 Introduction |
| 7.2 Market Overview |
| 7.2.1 Implantable Port Market Overview by Material |
| 7.2.2 Implantable Port Market Overview by Valve Type |
| 7.2.3 Implantable Port Market Overview by Device Properties |
| 7.3 Market Analysis and Forecast |
| 7.3.1 Total Implantable Port Market |
| 7.3.2 Implantable Port Market by Material |
| 7.3.2.1 Full Plastic Implantable Port Market |
| 7.3.2.1.1 Full Plastic Implantable Port Market by Lumen Number |
| 7.3.2.1.2 Full Plastic Implantable Port Market by Power-Injectability |
| 7.3.2.2 Full Titanium Implantable Port Market |
| 7.3.2.2.1 Full Titanium Implantable Port Market by Lumen Number |
| 7.3.2.2.2 Full Titanium Implantable Port Market by Power-Injectability |
| 7.3.2.3 Hybrid Implantable Port Market |
| 7.3.2.3.1 Hybrid Implantable Port Market by Lumen Number |
| 7.3.2.3.2 Hybrid Implantable Port Market by Power-Injectability |
| 7.3.3 Implantable Port Market by Valve Type |
| 7.3.3.1 Valved Implantable Port Market |
| 7.3.3.2 Non-Valved Implantable Port Market |
| 7.3.4 Implantable Port Market by Device Properties |
| 7.3.4.1 Antithrombogenic Implantable Port Market |
| 7.3.4.2 Conventional Implantable Port Market |
| 7.4 Drivers and Limiters |
| 7.4.1 Market Drivers |
| 7.4.2 Market Limiters |
| 7.5 Competitive Market Share Analysis |
| Port Needle Market |
| 8.1 Introduction |
| 8.2 Market Overview |
| 8.3 Market Analysis and Forecast |
| 8.3.1 Total Port Needle Market |
| 8.3.2 Port Needle Market by Setting |
| 8.3.2.1 Acute Care Port Needle Market by Device Type |
| 8.3.2.1.1 Acute Care Conventional Port Needle Market by Y-Site |
| 8.3.2.1.2 Acute Care Safety Port Needle Market |
| 8.3.2.2 Alternate Care Port Needle Market by Device Type |
| 8.3.2.2.1 Alternate Care Conventional Port Needle Market by Y-Site |
| 8.3.2.2.2 Alternate Care Safety Port Needle Market |
| 8.4 Drivers and Limiters |
| 8.4.1 Market Drivers |
| 8.4.2 Market Limiters |
| 8.5 Competitive Market Share Analysis |
| Central Venous Catheter Market |
| 9.1 Introduction |
| 9.2 Market Overview |
| 9.3 Market Analysis and Forecast |
| 9.3.1 Total Central Venous Catheter Market |
| 9.3.2 Acute Central Venous Catheter Market |
| 9.3.2.1 Conventional Acute Central Venous Catheter Market by Device Type |
| 9.3.2.1.1 Single-Lumen Conventional Acute Central Venous Catheter Market |
| 9.3.2.1.2 Multi-Lumen Conventional Acute Central Venous Catheter Market |
| 9.3.2.2 Antimicrobial Acute Central Venous Catheter Market |
| 9.3.2.2.1 Antimicrobial Acute Central Venous Catheter Market by Device Type |
| 9.3.2.2.2 Antimicrobial Acute Central Venous Catheter Market by Lumen Count |
| 9.3.2.3 Acute Central Venous Catheter Market by Power-Injectability |
| 9.3.2.3.1 Power-Injectable Acute Central Venous Catheter Market |
| 9.3.2.3.2 Non-Power-Injectable Acute Central Venous Catheter Market |
| 9.3.3 Chronic Central Venous Catheter Market |
| 9.3.3.1 Chronic Central Venous Catheter Market by Power-Injectability |
| 9.3.3.1.1 Power-Injectable Chronic Central Venous Catheter Market |
| 9.3.3.1.2 Non-Power-Injectable Chronic Central Venous Catheter Market |
| 9.3.3.2 Chronic Central Venous Catheter Market by Device Type |
| 9.3.3.2.1 Advanced Materials Chronic Central Venous Catheter Market |
| 9.3.3.2.2 Conventional Chronic Central Venous Catheter Market |
| 9.4 Drivers and Limiters |
| 9.4.1 Market Drivers |
| 9.4.2 Market Limiters |
| 9.5 Competitive Market Share Analysis |
| Peripherally inserted central catheter Market |
| 10.1 Introduction |
| 10.2 Market Overview |
| 10.2.1 Peripherally Inserted Central Catheter Market Overview by Tip-Placement Type |
| 10.2.2 Peripherally Inserted Central Catheter Market Overview by Care Setting |
| 10.2.3 Peripherally Inserted Central Catheter Market Overview by Valve Type |
| 10.2.4 Peripherally Inserted Central Catheter Market Overview by Kit Type |
| 10.3 Market Analysis and Forecast |
| 10.3.1 Total Peripherally Inserted Central Catheter Market |
| 10.3.2 Peripherally Inserted Central Catheter Market by Tip-Placement Type |
| 10.3.2.1 Tip-Placement Peripherally Inserted Central Catheter Kit Market by Lumen Number |
| 10.3.2.1.1 Single-Lumen Tip-Placement Peripherally Inserted Central Catheter Kit Market |
| 10.3.2.1.2 Double-Lumen Tip-Placement Peripherally Inserted Central Catheter Kit Market |
| 10.3.2.1.3 Triple-Lumen Tip-Placement Peripherally Inserted Central Catheter Kit Market |
| 10.3.2.1 Tip-Placement Peripherally Inserted Central Catheter Kit Market by Device Type |
| 10.3.2.1.1 Non-Power-Injectable Tip-Placement Peripherally Inserted Central Catheter Kit Market |
| 10.3.2.1.2 Power-Injectable Tip-Placement Peripherally Inserted Central Catheter Kit Market |
| 10.3.2.2 Basic Peripherally Inserted Central Catheter Kit Market by Lumen Number |
| 10.3.2.2.1 Single-Lumen Basic Peripherally Inserted Central Catheter Kit Market |
| 10.3.2.2.2 Double-Lumen Basic Peripherally Inserted Central Catheter Kit Market |
| 10.3.2.2.3 Triple-Lumen Basic Peripherally Inserted Central Catheter Kit Market |
| 10.3.2.3 Basic Peripherally Inserted Central Catheter Kit Market by Device Type |
| 10.3.2.3.1 Non-Power-Injectable Basic Peripherally Inserted Central Catheter Kit Market |
| 10.3.2.3.2 Power-Injectable Basic Peripherally Inserted Central Catheter Kit Market |
| 10.3.3 Peripherally Inserted Central Catheter Market by Care Setting |
| 10.3.3.1 Hospital-Based Peripherally Inserted Central Catheter Market |
| 10.3.3.2 Non-Hospital-Based Peripherally Inserted Central Catheter Market |
| 10.3.4 Peripherally Inserted Central Catheter Market by Valve Type |
| 10.3.4.1 Valved Peripherally Inserted Central Catheter Market |
| 10.3.4.2 Non-Valved Peripherally Inserted Central Catheter Market |
| 10.3.5 Peripherally Inserted Central Catheter Market by Kit Type |
| 10.3.5.1 Long Guidewire Peripherally Inserted Central Catheter Kit Market |
| 10.3.5.2 Standard Peripherally Inserted Central Catheter Kit Market |
| 10.4 Unit Analysis |
| 10.4.1 Peripherally Inserted Central Catheter Units Sold by Material |
| 10.4.2 Peripherally Inserted Central Catheter Units Sold by Material and Lumen Number |
| 10.4.3 Peripherally Inserted Central Catheter Units Placed by Material Type and Age Group |
| 10.5 Drivers and Limiters |
| 10.5.1 Market Drivers |
| 10.5.2 Market Limiters |
| 10.6 Competitive Market Share Analysis |
| Peripheral intravenous catheter Market |
| 11.1 Introduction |
| 11.2 Market Overview |
| 11.2.1 Peripheral Intravenous Catheter Market Overview by Device Type |
| 11.2.2 Peripheral Intravenous Catheter Market Overview by Setting |
| 11.3 Market Analysis and Forecast |
| 11.3.1 Total Peripheral Intravenous Catheter Market |
| 11.3.2 Peripheral Intravenous Catheter Market by Segment |
| 11.3.2.1 Conventional Peripheral Intravenous Catheter Market |
| 11.3.2.2 Safety Peripheral Intravenous Catheter Market by Type |
| 11.3.2.2.1 Blood Control Safety Peripheral Intravenous Catheter Market by Type |
| 11.3.2.2.2 Non-Blood Control Safety Peripheral Intravenous Catheter Market by Type |
| 11.3.3 Peripheral Intravenous Catheter Market by Setting |
| 11.3.3.1 Acute Care Peripheral Intravenous Catheter Market |
| 11.3.3.2 Alternate Care Peripheral Intravenous Catheter Market |
| 11.3.3.2.1 Home Care Peripheral Intravenous Catheter Market |
| 11.3.3.2.2 Outpatient and Nursing Home Care Peripheral Intravenous Catheter Market |
| 11.4 Unit Analysis |
| 11.4.1 Peripheral Intravenous Catheter Units Sold by Length |
| 11.4.2 Peripheral Intravenous Catheter Units Sold by Insertion Site |
| 11.4.3 Peripheral Intravenous Catheter Units Sold by Insertion Technique |
| 11.5 Drivers and Limiters |
| 11.5.1 Market Drivers |
| 11.5.2 Market Limiters |
| 11.6 Competitive Market Share Analysis |
| MIDLINE Market |
| 12.1 Introduction |
| 12.2 Market Overview |
| 12.3 Market Analysis and Forecast |
| 12.3.1 Midline Market |
| 12.3.2 Midline Market by Insertion Method |
| 12.3.2.1 AST Midline Market |
| 12.3.2.2 MST Midline Market |
| 12.3.2.2.1 Power-Injectable MST Midline Market |
| 12.3.2.2.2 Non-Power-Injectable MST Midline Market |
| 12.4 Drivers and Limiters |
| 12.4.1 Market Drivers |
| 12.4.2 Market Limiters |
| 12.5 Competitive Market Share Analysis |
| Extended Dwell Catheter Market |
| 13.1 Introduction |
| 13.2 Market Analysis and Forecast |
| 13.3 Drivers and Limiters |
| 13.3.1 Market Drivers |
| 13.3.2 Market Limiters |
| 13.4 Competitive Market Share Analysis |
| Dialysis Catheter Market |
| 14.1 Introduction |
| 14.2 Market Overview |
| 14.3 Market Analysis and Forecast |
| 14.3.1 Dialysis Catheter Market |
| 14.3.2 Hemodialysis Catheter Market |
| 14.3.2.1 Long-Term Hemodialysis Catheter Market by Device Type |
| 14.3.2.1.1 Conventional Long-Term Hemodialysis Catheter Market |
| 14.3.2.1.2 Advanced Material Long-Term Hemodialysis Catheter Market |
| 14.3.2.2 Long-Term Hemodialysis Catheter Market by Care Setting |
| 14.3.2.2.1 In Center Long-Term Hemodialysis Catheter Market |
| 14.3.2.2.2 Home Care Long-Term Hemodialysis Catheter Market |
| 14.3.2.3 Short-Term Hemodialysis Catheter Market |
| 14.3.2.3.1 Power-Injectable Short-Term Hemodialysis Catheter Market |
| 14.3.2.3.2 Non-Power-Injectable Short-Term Hemodialysis Catheter Market |
| 14.3.3 Peritoneal Dialysis Catheter Market |
| 14.4 Drivers and Limiters |
| 14.4.1 Market Drivers |
| 14.4.2 Market Limiters |
| 14.5 Competitive Market Share Analysis |
| Ultrasound Vascular Access Device and Accessory Market |
| 15.1 Introduction |
| 15.2 Market Overview |
| 15.3 Market Analysis and Forecast |
| 15.3.1 Ultrasound Vascular Access Device and Accessory Market |
| 15.3.1.1 Cart-Based Ultrasound System Specialized for Vascular Access Market |
| 15.3.1.2 Hand-Carried and Portable Ultrasound System Specialized for Vascular Access Market |
| 15.4 Drivers and Limiters |
| 15.4.1 Market Drivers |
| 15.4.2 Market Limiters |
| 15.5 Competitive Market Share Analysis |
| Vein Visualization Technology Market |
| 16.1 Introduction |
| 16.2 Market Analysis and Forecast |
| 16.3 Drivers and Limiters |
| 16.3.1 Market Drivers |
| 16.3.2 Market Limiters |
| 16.4 Competitive Market Share Analysis |
| Tip-Placement System and Accessory Market |
| 17.1 Introduction |
| 17.2 Market Overview |
| 17.3 Market Analysis and Forecast |
| 17.3.1 Tip-Placement System Market |
| 17.3.1.1 Standalone Tip-Placement System Market |
| 17.3.1.2 Integrated Tip-Placement System Market |
| 17.3.2 Disposable Tip-Placement Accessory Market |
| 17.4 Drivers and Limiters |
| 17.4.1 Market Drivers |
| 17.4.2 Market Limiters |
| 17.5 Competitive Market Share Analysis |
| Catheter Securement Market |
| 18.1 Introduction |
| 18.1.1 Tape and Dressings |
| 18.1.2 Manufactured Catheter Securement Devices |
| 18.1.3 Sutures |
| 18.1.4 IV Site Protection Devices |
| 18.2 Market Overview |
| 18.3 Market Analysis and Forecast |
| 18.3.1 Tape and Dressing Market |
| 18.3.1.1 Antimicrobial Tape and Dressing Market |
| 18.3.1.2 Standard Tape and Dressing Market |
| 18.3.2 Suture Market |
| 18.3.3 Manufactured Catheter Securement Device Market |
| 18.3.3.1 Mechanical Manufactured Catheter Securement Device Market |
| 18.3.3.2 Non-Mechanical Manufactured Catheter Securement Device Market |
| 18.4 Unit Analysis |
| 18.4.1 Manufactured Catheter Securement Device Units Sold by Catheter Type |
| 18.5 Drivers and Limiters |
| 18.5.1 Market Drivers |
| 18.5.2 Market Limiters |
| 18.6 Competitive Market Share Analysis |
| Antibacterial Catheter Patch Market |
| 19.1 Introduction |
| 19.2 Market Analysis and Forecast |
| 19.3 Drivers and Limiters |
| 19.3.1 Market Drivers |
| 19.3.2 Market Limiters |
| 19.4 Competitive Market Share Analysis |
| Catheter Cap Market |
| 20.1 Introduction |
| 20.2 Market Overview |
| 20.3 Market Analysis and Forecast |
| 20.3.1 Catheter Cap Market |
| 20.3.2 Standard Catheter Cap Market |
| 20.3.3 Dialysis Catheter Cap Market |
| 20.4 Drivers and Limiters |
| 20.4.1 Market Drivers |
| 20.4.2 Market Limiters |
| 20.5 Competitive Market Share Analysis |
| Syringe and Needle Market |
| 21.1 Introduction |
| 21.2 Market Overview |
| 21.3 Market Analysis and Forecast |
| 21.3.1 Syringe Market |
| 21.3.1.1 Conventional Syringe Market |
| 21.3.1.2 Sliding Sleeve Safety Syringe Market |
| 21.3.1.3 Retractable Safety Syringe Market |
| 21.3.1.4 Hinged Safety Syringe Market |
| 21.3.1.5 Insulin Syringe Market by Usage |
| 21.3.1.5.1 Personal Insulin Syringe Market |
| 21.3.1.5.2 Professional Insulin Syringe Market |
| 21.3.1.6 Insulin Syringe Market by Device Type |
| 21.3.1.6.1 Safety Insulin Syringe Market |
| 21.3.1.6.2 Non-Safety Insulin Syringe Market |
| 21.3.2 Needle Market |
| 21.3.2.1 Conventional Needle Market |
| 21.3.2.2 Shielding Safety Needle Market |
| 21.3.2.3 Pivoting Needle Market |
| 21.3.2.4 Blunt Fill Needle Market |
| 21.3.2.5 Insulin Pen Needle Market |
| 21.3.2.5.1 Safety Insulin Pen Needle Market |
| 21.3.2.5.2 Non-Safety Insulin Pen Needle Market |
| 21.4 Drivers and Limiters |
| 21.4.1 Market Drivers |
| 21.4.2 Market Limiters |
| 21.5 Competitive Market Share Analysis |
| Appendix: Multi-purpose hand-carried and portable Ultrasound Market |
| 22.1 Introduction |
| 22.2 Market Analysis and Forecast |
| 22.3 Competitive Market Share Analysis |
| Abbreviations |
Companies Included:
| · 3M | · Johnson & Johnson |
| · Access Scientific | · Kawasumi |
| · AccuVein | · Kendall Medical |
| · Adhezion Biomedical | · Lineus Medical |
| · AngioDynamics | · M.C. Johnson |
| · Argon Medical | · Marvao Medical |
| · Arrow | · Medcomp |
| · Ash Access | · Medical Plastic |
| · B. Braun | · Medikit |
| · Baxter | · Medline |
| · Becton Dickinson | · MedSource |
| · Biolife | · Medtronic |
| · C.R. Bard | · Merit Medical |
| · Cardinal Health | · MidAmerica |
| · Centurion Medical | · MYCO Medical |
| · Christie Medical Holdings | · Navilyst |
| · Cook Medical | · Neo Medical |
| · Covidien | · Nipro Medical |
| · DaVita | · Nostix |
| · DeRoyal | · Novation |
| · Echonous | · Novo Nordisk |
| · Esaote North America | · Owen Mumford |
| · Ethicon | · Pathway NPI |
| · Fresenius | · PFM Medical |
| · FUJIFILM SonoSite | · Protectus |
| · GE Healthcare | · Pursuit Vascular |
| · Health Line Medical Products | · Retractable Technologies |
| · HealthTrust | · Siemens Medical Solutions |
| · ICU Medical | · Smith & Nephew |
| · Interrad Medical | · Smiths Medical |
List of Charts
| Chart 1‑1: Vascular Access Devices and Accessories Market by Segment, U.S., 2022 – 2029 |
| Chart 1‑2: Vascular Access Devices and Accessories Market Overview, U.S., 2022 & 2029 |
| Chart 2‑1: Multi-Scenario Vascular Access Devices and Accessories Market Forecast, U.S., 2019 – 2029 (US$M) |
| Chart 5‑1: Vascular Access Devices and Accessories Market by Segment, U.S., 2019 – 2029 |
| Chart 5‑2: Leading Competitors, Vascular Access Devices and Accessories Market, U.S., 2022 |
| Chart 6‑1: Vascular Access Procedure Numbers, U.S., 2019 – 2029 |
| Chart 7‑1: Implantable Port Market by Material, U.S., 2019 – 2029 |
| Chart 7‑2: Implantable Port Market by Valve Type, U.S., 2019 – 2029 |
| Chart 7‑3: Implantable Port Market by Device Properties, U.S., 2019 – 2029 |
| Chart 7‑4: Leading Competitors, Implantable Port Market, U.S., 2022 |
| Chart 8‑1: Port Needle Market by Setting, U.S., 2019 – 2029 |
| Chart 8‑2: Leading Competitors, Port Needle Market, U.S., 2022 |
| Chart 9‑1: Central Venous Catheter Market by Device Type, U.S., 2019 – 2029 |
| Chart 9‑2: Leading Competitors, Central Venous Catheter Market, U.S., 2022 |
| Chart 10‑1: Peripherally Inserted Central Catheter Market by Tip-Placement Type, U.S., 2019 – 2029 |
| Chart 10‑2: Leading Competitors, Peripherally Inserted Central Catheter Market, U.S., 2022 |
| Chart 11‑1: Peripheral Intravenous Catheter Market by Segment, U.S., 2019 – 2029 |
| Chart 11‑2: Leading Competitors, Peripheral Intravenous Catheter Market, U.S., 2022 |
| Chart 12‑1: Midline Market by Insertion Method, U.S., 2019 – 2029 |
| Chart 12‑2: Leading Competitors, Midline Market, U.S., 2022 |
| Chart 13‑1: Extended Dwell Catheter Market, U.S., 2019 – 2029 |
| Chart 13‑2: Leading Competitors, Extended Dwell Catheter Market, U.S., 2022 |
| Chart 14‑1: Dialysis Catheter Market by Segment, U.S., 2019 – 2029 |
| Chart 14‑2: Leading Competitors, Dialysis Catheter Market, U.S., 2022 |
| Chart 15‑1: Ultrasound Vascular Access Device and Accessory Market by Segment, U.S., 2019 – 2029 |
| Chart 15‑2: Leading Competitors, Ultrasound Vascular Access Device and Accessory Market, U.S., 2022 |
| Chart 16‑1: Vein Visualization Technology Market, U.S., 2019 – 2029 |
| Chart 16‑2: Leading Competitors, Vein Visualization Technology Market, U.S., 2022 |
| Chart 17‑1: Tip-Placement System and Accessory Market by Segment, U.S., 2019 – 2029 |
| Chart 17‑2: Leading Competitors, Tip-Placement System and Accessory Market, U.S., 2022 |
| Chart 18‑1: Catheter Securement Market by Segment, U.S., 2019 – 2029 |
| Chart 18‑2: Leading Competitors, Catheter Securement Market, U.S., 2022 |
| Chart 19‑1: Antibacterial Catheter Patch Market, U.S., 2019 – 2029 |
| Chart 19‑2: Leading Competitors, Antibacterial Catheter Patch Market, U.S., 2022 |
| Chart 20‑1: Catheter Cap Market by Segment, U.S., 2019 – 2029 |
| Chart 20‑2: Leading Competitors, Catheter Cap Market, U.S., 2022 |
| Chart 21‑1: Syringe and Needle Market by Segment, U.S., 2019 – 2029 |
| Chart 21‑2: Leading Competitors, Syringe and Needle Market, U.S., 2022 |
List of Figures
| Figure 1‑1: Vascular Access Devices and Accessories Market Share Ranking by Segment, U.S., 2022 (1 of 3) |
| Figure 1‑2: Vascular Access Devices and Accessories Market Share Ranking by Segment, U.S., 2022 (2 of 3) |
| Figure 1‑3: Vascular Access Devices and Accessories Market Share Ranking by Segment, U.S., 2022 (3 of 3) |
| Figure 1‑4: Companies Researched in This Report (1 of 2) |
| Figure 1‑5: Companies Researched in This Report (2 of 2) |
| Figure 1‑6: Factors Impacting the Vascular Access Devices and Accessories Market by Segment, U.S. (1 of 3) |
| Figure 1‑7: Factors Impacting the Vascular Access Devices and Accessories Market by Segment, U.S. (2 of 3) |
| Figure 1‑8: Factors Impacting the Vascular Access Devices and Accessories Market by Segment, U.S. (3 of 3) |
| Figure 1‑9: Recent Events in the Vascular Access Devices and Accessories Market, U.S., 2019 – 2022 (1 of 2) |
| Figure 1‑10: Recent Events in the Vascular Access Devices and Accessories Market, U.S., 2019 – 2022 (2 of 2) |
| Figure 1‑11: Vascular Access Devices and Accessories Procedures Covered (1 of 4) |
| Figure 1‑12: Vascular Access Devices and Accessories Procedures Covered (2 of 4) |
| Figure 1‑13: Vascular Access Devices and Accessories Procedures Covered (3 of 4) |
| Figure 1‑14: Vascular Access Devices and Accessories Procedures Covered (4 of 4) |
| Figure 1‑15: Procedure Codes Investigated |
| Figure 1‑16: Vascular Access Devices and Accessories Markets Covered (1 of 8) |
| Figure 1‑17: Vascular Access Devices and Accessories Markets Covered (2 of 8) |
| Figure 1‑18: Vascular Access Devices and Accessories Markets Covered (3 of 8) |
| Figure 1‑19: Vascular Access Devices and Accessories Markets Covered (4 of 8) |
| Figure 1‑20: Vascular Access Devices and Accessories Markets Covered (5 of 8) |
| Figure 1‑21: Vascular Access Devices and Accessories Markets Covered (6 of 8) |
| Figure 1‑22: Vascular Access Devices and Accessories Markets Covered (7 of 8) |
| Figure 1‑23: Vascular Access Devices and Accessories Markets Covered (8 of 8) |
| Figure 1‑24: Key Report Updates (1 of 2) |
| Figure 1‑25: Key Report Updates (2 of 2) |
| Figure 1‑26: Version History |
| Figure 2‑1: Vascular Access Devices and Accessories Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2) |
| Figure 2‑2: Vascular Access Devices and Accessories Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2) |
| Figure 2‑3: Vascular Access Devices and Accessories Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2) |
| Figure 2‑4: Vascular Access Devices and Accessories Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2) |
| Figure 2‑5: Vascular Access Devices and Accessories Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 2) |
| Figure 2‑6: Vascular Access Devices and Accessories Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 2) |
| Figure 4‑1: Implantable Ports by Company |
| Figure 4‑2: Port Needles by Company (1 of 2) |
| Figure 4‑3: Port Needles by Company (2 of 2) |
| Figure 4‑4: Central Venous Catheters by Company |
| Figure 4‑5: Peripherally Inserted Central Catheters by Company |
| Figure 4‑6: Peripheral Intravenous Catheters by Company |
| Figure 4‑7: Midlines by Company |
| Figure 4‑8: Extended Dwell Catheter by Company |
| Figure 4‑9: Dialysis Catheters by Company (1 of 2) |
| Figure 4‑10: Dialysis Catheters by Company (2 of 2) |
| Figure 4‑11: Ultrasound Vascular Access Devices and Accessories by Company |
| Figure 4‑12: Vein Visualization by Company |
| Figure 4‑13: Tip-Placement System and Accessories by Company |
| Figure 4‑14: Catheter Securement by Company (1 of 2) |
| Figure 4‑15: Catheter Securement by Company (2 of 2) |
| Figure 4‑16: Antibacterial Catheter Patch by Company |
| Figure 4‑17: Catheter Cap by Company |
| Figure 4‑18: Syringes and Needles by Company (1 of 2) |
| Figure 4‑19: Syringes and Needles by Company (2 of 2) |
| Figure 4‑20: Class 2 Device Recall PowerPort duo M.R.I. Implantable Port |
| Figure 4‑21: Class 2 Device Recall Smart Port CT |
| Figure 4‑22: Class 2 Device Recall PORTACATH II POWER P.A.C. Low Profile" System |
| Figure 4‑23: Class 2 Device Recall BARD Access Systems PowerPort ClearVUE Slim Implantable Port |
| Figure 4‑24: Class 2 Device Recall Vaccess CT PowerInjectable Implantable Port |
| Figure 4‑25: Class 2 Device Recall XPort isp M.R.I. Implantable Port |
| Figure 4‑26: Class 2 Device Recall Power Port Implantable Port |
| Figure 4‑27: Class 2 Device Recall PowerPort M.R.I. Implantable Port |
| Figure 4‑28: Class 2 Device Recall BardPort Titanium Implantable Port |
| Figure 4‑29: Class 2 Device Recall BardPort M.R.I. Hard Base Implantable Port |
| Figure 4‑30: Class 2 Device Recall Powerport Cleavue Slim Implantable Port |
| Figure 4‑31: Class 2 Device Recall Bard Access Systems PowerPort isp M.R.I. Implantable Port |
| Figure 4‑32: Class 2 Device Recall BioFlo Port with ENDEXO and PASV Technology |
| Figure 4‑33: Class 2 Device Recall Port Access Kit |
| Figure 4‑34: Class 2 Device Recall SafeStep Huber Needle Set |
| Figure 4‑35: Class 2 Device Recall PowerLoc MAX Power |
| Figure 4‑36: Class 2 Device Recall GRIPPER Needles |
| Figure 4‑37: Class 1 Device Recall Arrow Pressure Injectable Arrowgard Blue Plus ThreeLumen CVC Kit |
| Figure 4‑38: Class 2 Device Recall Arrow ThreeLumen CVC |
| Figure 4‑39: Class 2 Device Recall Arrow Teleflex |
| Figure 4‑40: Class 2 Device Recall Groshong CV Catheter |
| Figure 4‑41: Class 2 Device Recall Centurion |
| Figure 4‑42: Class 2 Device Recall Arrow AGB MultiLumen CVC Kit |
| Figure 4‑43: Class 2 Device Recall ARROWgard Blue Plus |
| Figure 4‑44: Class 2 Device Recall ARROWgard Blue Plus MultiLumen CVC Kit |
| Figure 4‑45: Class 2 Device Recall PICC KIT |
| Figure 4‑46: Class 2 Device Recall Various PICC Line, Central Line Packs |
| Figure 4‑47: Class 2 Device Recall Navilyst |
| Figure 4‑48: Class 2 Device Recall 5Fr PowerPICC Catheter SingleLumen with 70cm Guidewire |
| Figure 4‑49: Class 2 Device Recall BioFlo and Xcela |
| Figure 4‑50: Class 2 Device Recall Arrow PICC |
| Figure 4‑51: Class 2 Device Recall Arrow Pressure Injectable PICC |
| Figure 4‑52: Class 2 Device Recall Navilyst Medical BioFlo PICC with ENDEXO and PASV |
| Figure 4‑53: Class 2 Device Recall BD Nexiva Closed IV Catheter System |
| Figure 4‑54: Class 2 Device Recall BD Nexiva 20 GA 1.00 (1.1 x 25mm) Dual Port |
| Figure 4‑55: Class 2 Device Recall DELTAVEN Safety I.V. Catheter in Pur with closed system |
| Figure 4‑56: Class 2 Device Recall B. Braun Introcan Safety IV Catheters |
| Figure 4‑57: Class 2 Device Recall BD Nexiva Closed IV Catheter System Dual Port |
| Figure 4‑58: Class 2 Device Recall BD Nexiva Closed IV Catheter System |
| Figure 4‑59: Class 2 Device Recall Jelco(R) ViaValve(TM) Safety Intravenous (I.V.) Catheters |
| Figure 4‑60: Class 2 Device Recall ARROW Pressure Injectable Arrowgard Blue Advance Midline Kit |
| Figure 4‑61: Class 2 Device Recall PowerMidline Catheter |
| Figure 4‑62: Class 2 Device Recall BioFlo Midline |
| Figure 4‑63: Class 2 Device Recall PowerGlide ST Midline Catheter Maximal Barrier |
| Figure 4‑64: Class 2 Device Recall Arrowgard Blue Advance Midline |
| Figure 4‑65: Class 2 Device Recall Peripherally Inserted Midline Catheter Kit with Placement Wire |
| Figure 4‑66: Class 3 Device Recall POWERWAND XL 4Fr 10cm Maximum Barrier Kit |
| Figure 4‑67: Class 2 Device Recall Arrow Endurance Catheter System |
| Figure 4‑68: Class 1 Device Recall Mahurkar |
| Figure 4‑69: Class 1 Device Recall Hemodialysis Catheter |
| Figure 4‑70: Class 2 Device Recall Hemodialysis Implanted Catheter |
| Figure 4‑71: Class 2 Device Recall PowerTrialysis ShortTerm Alphacurve Dialysis Catheter |
| Figure 4‑72: Class 2 Device Recall EQUISTREAM LongTerm Hemodialysis Catheter |
| Figure 4‑73: Class 2 Device Recall GLIDEPATH LongTerm Hemodialysis Catheter |
| Figure 4‑74: Class 2 Device Recall 14F SLX Double Lumen Full Tray |
| Figure 4‑75: Class 2 Device Recall MAHURKAR" and Argyle" Acute Hemodialysis Catheters |
| Figure 4‑76: Class 2 Device Recall 14F SLX Double Lumen Full Tray |
| Figure 4‑77: Class 2 Device Recall Vivid |
| Figure 4‑78: Class 2 Device Recall ACUSON Juniper Diagnostic Ultrasound System |
| Figure 4‑79: Class 2 Device Recall Vscan Extend System, Imaging, Pulsed Echo, Ultrasonic |
| Figure 4‑80: Class 2 Device Recall AC/DC POWER SUPPLY for 7400 |
| Figure 4‑81: Class 2 Device Recall SiteRite 8 Ultrasound Systems |
| Figure 4‑82: Class 2 Device Recall VPS Rhythm ECG Accessory Pack |
| Figure 4‑83: Class 2 Device Recall Busse I.V. START KIT |
| Figure 4‑84: Class 2 Device Recall MERSILK and PERMAHAND, Braided Silk and Virgin Silk NonAbsorbable Suture |
| Figure 4‑85: Class 2 Device Recall Coated VICRYL (Polyglactin 910) Suture |
| Figure 4‑86: Class 2 Device Recall ETHIBOND EXCEL ETHIBOND Polyester Suture |
| Figure 4‑87: Class 2 Device Recall 3M Durapore Advanced Surgical Tape |
| Figure 4‑88: Class 2 Device Recall HEB InControl Insulin Syringe |
| Figure 4‑89: Class 1 Device Recall Monoject 0.9 Sodium Chloride Flush Syringe |
| Figure 4‑90: Class 1 Device Recall JELCO HYPODERMIC NEEDLEPRO FIXED NEEDLE INSULIN SYRINGE |
| Figure 4‑91: Class 2 Device Recall Covidien |
| Figure 4‑92: Class 2 Device Recall BD PrecisionGlide Needle 30G x 1/2 |
| Figure 4‑93: Class 2 Device Recall BD UltraFine Pen Needles 32G x 4mm |
| Figure 4‑94: Class 2 Device Recall Monoject Standard Hypodermic Needle |
| Figure 4‑95: Class 2 Device Recall BD SafetyGlideTM 3ml 25G x 1 |
| Figure 4‑96: Class 2 Device Recall Monoject Hypodermic Safety Needle |
| Figure 4‑97: Class 2 Device Recall GRIPPER Needles |
| Figure 4‑98: Class 2 Device Recall 3mL SafetyLok Syringe |
| Figure 4‑99: Class 2 Device Recall 3mL LuerLok Syringe |
| Figure 4‑100: Safety of Extending the Routine Flushing of Implanted Port Devices from 4 Weeks to 12 |
| Figure 4‑101: Interest of Virtual Reality to Reduce Patient Anxiety During the Placement of a Percutaneous Implantable Port Catheter (RV-CIP) |
| Figure 4‑102: A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports |
| Figure 4‑103: Comparison Between Internal Jugular Vein Versus Axillary Vein for Implantable Ports |
| Figure 4‑104: Maintaining Patency in Implanted Port Catheters |
| Figure 4‑105: Ultrasound Guided Port-A-Cath Insertion in Cancer Patients |
| Figure 4‑106: Study on Indications of "Bard" PowerPort Isp Implantable Port (BPIP) |
| Figure 4‑107: Wire-in-needle vs. Traditional Technique for Ultrasound-Guided Central Venous Catheter Placement |
| Figure 4‑108: Central Venous Catheter-Related Complications in Patients Under Anticancer Treatment (KTcCHO) |
| Figure 4‑109: Infection Related to Short-Term Central Venous Catheters |
| Figure 4‑110: Point of Care Ultrasonography Versus Standard Blind Technique for Central Venous Catheter Insertion in Emergency Hospital |
| Figure 4‑111: Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients |
| Figure 4‑112: Novel Strategy to Encourage Early Removal of Central Venous Catheters |
| Figure 4‑113: Novel Strategy to Encourage Early Removal of Central Venous Catheters |
| Figure 4‑114: Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurosurgical Intensive Care Unit (PICINI) |
| Figure 4‑115: Comparing Peripherally Inserted Central Catheters to Long Peripheral Catheters in Pediatrics (ComPLET) |
| Figure 4‑116: Comparing Arrow PICC Catheters w/ Arrowga+rd Blue Advanced Protection Performance and Safety to Unprotected PICC's |
| Figure 4‑117: Prospective Observational Study of the Power PICC Family of Devices and Accessories |
| Figure 4‑118: Peripherally Inserted Central Catheter Insertion Site and Complication Rate in Neonates |
| Figure 4‑119: Major Complications Related to PICC and Midline Insertion (PICC/MIDLINE) |
| Figure 4‑120: Safety and Effectiveness of CATHTONG™ II PICC |
| Figure 4‑121: Ultrasound-Guided Peripheral Intravenous Catheter Insertion Technique (PIVC) |
| Figure 4‑122: Comparison of Two Peripheral Inserted Intravenous Catheters |
| Figure 4‑123: Impact of PIVC Length and Gauge on Catheter Indwell Time |
| Figure 4‑124: Impact of a Multimodal Intervention on Peripheral Venous Catheterization of Cancer Patients (MultiCat) |
| Figure 4‑125: Peripheral Intravenous Catheter Securement with Tissue Adhesive |
| Figure 4‑126: Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurosurgical Intensive Care Unit (PICINI) |
| Figure 4‑127: Midline Catheter and Its Impact on Central Lines Removal in ICU (MIDREA) |
| Figure 4‑128: Patient Perspective Midline Catheter in the Emergency Department |
| Figure 4‑129: Midline Failures: A Comparison Between a Hydrophilic Biomaterial and Thermoplastic Polyurethane |
| Figure 4‑130: Safety and Efficacy of Midline and PICC (MidLine_PICC) |
| Figure 4‑131: Midlines and Thrombophlebitis |
| Figure 4‑132: Midline Catheter and Its Impact on Central Lines Removal in ICU (MIDREA) |
| Figure 4‑133: Upper Limb Thrombosis Associated With Midline Catheter |
| Figure 4‑134: The Clinical Efficacy of Midline Catheters |
| Figure 4‑135: Occurrence of Emerging Infections After Placement of a Peritoneal Dialysis CatHeter (SINEPHILE) |
| Figure 4‑136: Tunneled Dialysis Catheters Versus Non-Tunneled Dialysis Catheters as First-Line for Renal Replacement Therapy in the ICU (BACKDOOR) |
| Figure 4‑137: Straight Versus Coiled Peritoneal Dialysis Catheter for Peritoneal Dialysis Patients |
| Figure 4‑138: A Percutaneous Ultrasound Device with Needle Guide for Vascular Access |
| Figure 4‑139: Ultrasound Guided Peripheral Catheterization Increases First-Attempt Success Rate (SPECTRA) |
| Figure 4‑140: Ultrasound-Guided Peripheral IV vs. Standard Technique in Difficult Vascular Access Patients by ICU Nurses |
| Figure 4‑141: Efficacy of an Infrared Visualization Technique for the Identification of the Peripheral Venous Access Site in Patients with Cystic Fibrosis Aged 12 Years and Older (MUCOVEINE) |
| Figure 4‑142: Infra Red Vein Visualization: Efficacy vs. Standard Technique |
| Figure 4‑143: Can Veinlite Reduce Complications of Peripheral Intravenous Catheter Placement in Children |
| Figure 4‑144: Innovative Central Line Securement Device in the Pediatric Population |
| Figure 4‑145: A New Securement Method for External Tunneled Central Venous Access Devices (CVAD) |
| Figure 4‑146: Comparison of Sterile Gauze and Semi-Permeable Film Dressing for Hemodialysis Central Venous Catheter |
| Figure 4‑147: A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices |
| Figure 4‑148: Prospective Healthy Volunteer Study of the Securis™ Stabilization Device |
| Figure 4‑149: Peripheral Intravenous Catheter Securement with Tissue Adhesive |
| Figure 5‑1: Vascular Access Devices and Accessories Market by Segment, U.S., 2019 – 2029 (US$M) (1 of 3) |
| Figure 5‑2: Vascular Access Devices and Accessories Market by Segment, U.S., 2019 – 2029 (US$M) (2 of 3) |
| Figure 5‑3: Vascular Access Devices and Accessories Market by Segment, U.S., 2019 – 2029 (US$M) (3 of 3) |
| Figure 5‑4: Leading Competitors, Vascular Access Devices and Accessories Market, U.S., 2022 (1 of 2) |
| Figure 5‑5: Leading Competitors, Vascular Access Devices and Accessories Market, U.S., 2022 (2 of 2) |
| Figure 5‑6: SWOT Analysis, 3M |
| Figure 5‑7: SWOT Analysis, AccuVein |
| Figure 5‑8: SWOT Analysis, AngioDynamics |
| Figure 5‑9: SWOT Analysis, B. Braun |
| Figure 5‑10: SWOT Analysis, Becton Dickinson (1 of 2) |
| Figure 5‑11: SWOT Analysis, Becton Dickinson (2 of 2) |
| Figure 5‑12: SWOT Analysis, Cardinal Health |
| Figure 5‑13: SWOT Analysis, FUJIFILM SonoSite |
| Figure 5‑14: SWOT Analysis, GE Healthcare |
| Figure 5‑15: SWOT Analysis, ICU Medical |
| Figure 5‑16: SWOT Analysis, Johnson & Johnson |
| Figure 5‑17: SWOT Analysis, Medcomp |
| Figure 5‑18: SWOT Analysis, Novo Nordisk |
| Figure 5‑19: SWOT Analysis, Teleflex Medical |
| Figure 6‑1: Procedure Codes Investigated, U.S., 2022 |
| Figure 6‑2: Vascular Access Procedure Numbers, U.S., 2019 – 2029 (1 of 2) |
| Figure 6‑3: Vascular Access Procedure Numbers, U.S., 2019 – 2029 (2 of 2) |
| Figure 6‑4: Implantable Port Insertion Procedures by Material, U.S., 2019 – 2029 |
| Figure 6‑5: Implantable Port Insertion Procedures by Valve Type, U.S., 2019 – 2029 |
| Figure 6‑6: Implantable Port Insertion Procedures by Power-Injectability, U.S., 2019 – 2029 |
| Figure 6‑7: Implantable Port Insertion Procedures by Location, U.S., 2019 – 2029 |
| Figure 6‑8: Implantable Port Insertion Procedures by Setting, U.S., 2019 – 2029 |
| Figure 6‑9: Implantable Port Insertion Procedures by Patient Age Group, U.S., 2019 – 2029 |
| Figure 6‑10: Implantable Port Insertion Procedures by Operator, U.S., 2019 – 2029 |
| Figure 6‑11: Port Needle Insertion Procedures by Setting, U.S., 2019 – 2029 |
| Figure 6‑12: Central Venous Catheter Insertion Procedures by Device Type, U.S., 2019 – 2029 |
| Figure 6‑13: Central Venous Catheter Insertion Procedures by Insertion Site U.S., 2019 – 2029 |
| Figure 6‑14: CVC Insertion Procedures by Imaging Technique, U.S., 2019 – 2029 |
| Figure 6‑15: Central Venous Catheter Insertion Procedures by Patient Type, U.S., 2019 – 2029 |
| Figure 6‑16: Peripherally Inserted Central Catheter Insertion Procedures by Power-Injectability, U.S., 2019 – 2029 |
| Figure 6‑17: Peripherally Inserted Central Catheter Insertion Procedures by Patient Age Group, U.S., 2019 – 2029 |
| Figure 6‑18: Peripherally Inserted Central Catheter Insertion Procedures by Operator, U.S., 2019 – 2029 |
| Figure 6‑19: Peripherally Inserted Central Catheter Insertion Procedures by Setting, U.S., 2019 – 2029 |
| Figure 6‑20: Mean Peripheral Intravenous Catheters Used Per Procedure, U.S., 2019 – 2029 |
| Figure 6‑21: Peripheral Intravenous Catheter Insertion Procedures by Setting, U.S., 2019 – 2029 |
| Figure 6‑22: Peripheral Intravenous Catheter Insertion Procedures by Device Type, U.S., 2019 – 2029 |
| Figure 6‑23: Peripheral Intravenous Catheter Insertion Procedures by Insertion Site, U.S., 2019 – 2029 |
| Figure 6‑24: Peripheral Intravenous Catheter Insertion Procedures by Visualization Method, U.S., 2019 – 2029 |
| Figure 6‑25: Midline Placement Procedures by Device Type, U.S., 2019 – 2029 |
| Figure 6‑26: Midline Placement Procedures by Power-Injectability, U.S., 2019 – 2029 |
| Figure 6‑27: Extended Dwell Placement Procedures, U.S., 2019 – 2029 |
| Figure 6‑28: Dialysis Catheter Placement Procedures by Device Type, U.S., 2019 – 2029 |
| Figure 6‑29: Vascular Access Catheters Placed Using Ultrasound Guidance, U.S., 2019 – 2029 |
| Figure 6‑30: Vascular Access Catheters Placed Using Ultrasound Guidance by Operator, U.S., 2019 – 2029 |
| Figure 6‑31: PIVCs Placed Using Vein Visualization, U.S., 2019 – 2029 |
| Figure 6‑32: Vascular Access Catheters Placed Using Tip-Placement Devices by Catheter Type, U.S., 2019 – 2029 |
| Figure 6‑33: Vascular Access Catheters Placed Using Tip-Placement Device by Operator, U.S., 2019 – 2029 |
| Figure 7‑1: Implantable Port Market by Material, U.S., 2019 – 2029 (US$M) |
| Figure 7‑2: Implantable Port Market by Valve Type, U.S., 2019 – 2029 (US$M) |
| Figure 7‑3: Implantable Port Market by Device Properties, U.S., 2019 – 2029 (US$M) |
| Figure 7‑4: Total Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑5: Total Full Plastic Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑6: Full Plastic Implantable Port Market by Lumen Number, U.S., 2019 – 2029 (US$M) |
| Figure 7‑7: Single-Lumen Full Plastic Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑8: Double-Lumen Full Plastic Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑9: Full Plastic Implantable Port Market by Power-Injectability, U.S., 2019 – 2029 (US$M) |
| Figure 7‑10: Power-Injectable Full Plastic Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑11: Non-Power-Injectable Full Plastic Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑12: Total Full Titanium Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑13: Full Titanium Implantable Port Market by Lumen Number, U.S., 2019 – 2029 (US$M) |
| Figure 7‑14: Single-Lumen Full Titanium Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑15: Double-Lumen Full Titanium Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑16: Full Titanium Implantable Port Market by Power-Injectability, U.S., 2019 – 2029 (US$M) |
| Figure 7‑17: Power-Injectable Full Titanium Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑18: Non-Power-Injectable Full Titanium Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑19: Total Hybrid Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑20: Hybrid Implantable Port Market by Lumen Number, U.S., 2019 – 2029 (US$M) |
| Figure 7‑21: Single-Lumen Hybrid Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑22: Double-Lumen Hybrid Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑23: Hybrid Implantable Port Market by Power-Injectability, U.S., 2019 – 2029 (US$M) |
| Figure 7‑24: Power-Injectable Hybrid Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑25: Non-Power-Injectable Hybrid Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑26: Valved Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑27: Non-Valved Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑28: Antithrombogenic Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑29: Conventional Implantable Port Market, U.S., 2019 – 2029 |
| Figure 7‑30: Leading Competitors, Implantable Port Market, U.S., 2022 |
| Figure 8‑1: Port Needle Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 8‑2: Total Port Needle Market, U.S., 2019 – 2029 |
| Figure 8‑3: Acute Care Port Needle Market by Device Type, U.S., 2019 – 2029 |
| Figure 8‑4: Acute Care Port Needle Market, U.S., 2019 – 2029 |
| Figure 8‑5: Acute Care Conventional Port Needle Market by Y-Site, U.S., 2019 – 2029 |
| Figure 8‑6: Acute Care Conventional Port Needle Market, U.S., 2019 – 2029 |
| Figure 8‑7: Acute Care Conventional Port Needle With Y-Site Market, U.S., 2019 – 2029 |
| Figure 8‑8: Acute Care Conventional Port Needle Without Y-Site Market, U.S., 2019 – 2029 |
| Figure 8‑9: Acute Care Safety Port Needle Market, U.S., 2019 – 2029 |
| Figure 8‑10: Acute Care Safety Port Needle Market by Power-Injectability, U.S., 2019 – 2029 |
| Figure 8‑11: Acute Care Safety Power-Injectable Port Needle Market, U.S., 2019 – 2029 |
| Figure 8‑12: Acute Care Safety Non-Power-Injectable Port Needle Market, U.S., 2019 – 2029 |
| Figure 8‑13: Acute Care Safety Port Needle Market by Y-Site, U.S., 2019 – 2029 |
| Figure 8‑14: Acute Care Safety Port Needle With Y-Site Market, U.S., 2019 – 2029 |
| Figure 8‑15: Acute Care Safety Port Needle Without Y-Site Market, U.S., 2019 – 2029 |
| Figure 8‑16: Acute Care Safety Port Needle Market by Needleless Connector, U.S., 2019 – 2029 |
| Figure 8‑17: Acute Care Safety Port Needle With Needleless Connector Market, U.S., 2019 – 2029 |
| Figure 8‑18: Acute Care Safety Port Needle Without Needleless Connector Market, U.S., 2019 – 2029 |
| Figure 8‑19: Alternate Care Port Needle Market by Device Type, U.S., 2019 – 2029 |
| Figure 8‑20: Alternate Care Port Needle Market, U.S., 2019 – 2029 |
| Figure 8‑21: Alternate Care Conventional Port Needle Market by Y-Site, U.S., 2019 – 2029 |
| Figure 8‑22: Alternate Care Conventional Port Needle Market, U.S., 2019 – 2029 |
| Figure 8‑23: Alternate Care Conventional Port Needle With Y-Site Market, U.S., 2019 – 2029 |
| Figure 8‑24: Alternate Care Conventional Port Needle Without Y-Site Market, U.S., 2019 – 2029 |
| Figure 8‑25: Alternate Care Safety Port Needle Market, U.S., 2019 – 2029 |
| Figure 8‑26: Alternate Care Safety Port Needle Market by Power-Injectability, U.S., 2019 – 2029 |
| Figure 8‑27: Alternate Care Safety Power-Injectable Port Needle Market, U.S., 2019 – 2029 |
| Figure 8‑28: Alternate Care Safety Non-Power-Injectable Port Needle Market, U.S., 2019 – 2029 |
| Figure 8‑29: Alternate Care Safety Port Needle Market by Y-Site, U.S., 2019 – 2029 |
| Figure 8‑30: Alternate Care Safety Port Needle With Y-Site Market, U.S., 2019 – 2029 |
| Figure 8‑31: Alternate Care Safety Port Needle Without Y-Site Market, U.S., 2019 – 2029 |
| Figure 8‑32: Alternate Care Safety Port Needle Market by Needleless Connector, U.S., 2019 – 2029 |
| Figure 8‑33: Alternate Care Safety Port Needle With Needleless Connector Market, U.S., 2019 – 2029 |
| Figure 8‑34: Alternate Care Safety Port Needle Without Needleless Connector Market, U.S., 2019 – 2029 |
| Figure 8‑35: Leading Competitors, Port Needle Market, U.S., 2022 |
| Figure 9‑1: Central Venous Catheter Market by Device Type, U.S., 2019 – 2029 (US$M) |
| Figure 9‑2: Total Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑3: Acute Central Venous Catheter Market by Device Type, U.S., 2019 – 2029 (US$M) |
| Figure 9‑4: Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑5: Conventional Acute Central Venous Catheter Market by Device Type, U.S., 2019 – 2029 |
| Figure 9‑6: Conventional Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑7: Single-Lumen Conventional Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑8: Multi-Lumen Conventional Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑9: Antimicrobial Acute Central Venous Catheter Market by Device Type, U.S., 2019 – 2029 |
| Figure 9‑10: Antimicrobial Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑11: Impregnated Antimicrobial Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑12: Coated Antimicrobial Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑13: Antimicrobial Acute Central Venous Catheter Market by Lumen Count, U.S., 2019 – 2029 |
| Figure 9‑14: Antimicrobial Acute Central Venous Catheter Market by Lumen Count, U.S., 2019 – 2029 |
| Figure 9‑15: Single-Lumen Antimicrobial Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑16: Multi-Lumen Antimicrobial Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑17: Acute Central Venous Catheter Market by Power-Injectability, U.S., 2019 – 2029 (US$M) |
| Figure 9‑18: Total Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑19: Power-Injectable Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑20: Non-Power-Injectable Acute Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑21: Total Chronic Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑22: Chronic Central Venous Catheter Market by Power-Injectability, U.S., 2019 – 2029 (US$M) |
| Figure 9‑23: Power-Injectable Chronic Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑24: Non-Power-Injectable Chronic Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑25: Chronic Central Venous Catheter Market by Device Type, U.S., 2019 – 2029 (US$M) |
| Figure 9‑26: Advanced Materials Chronic Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑27: Conventional Chronic Central Venous Catheter Market, U.S., 2019 – 2029 |
| Figure 9‑28: Leading Competitors, Central Venous Catheter Market, U.S., 2022 |
| Figure 10‑1: Peripherally Inserted Central Catheter Market by Tip-Placement Type, U.S., 2019 – 2029 (US$M) |
| Figure 10‑2: Peripherally Inserted Central Catheter Market by Care Setting, U.S., 2019 – 2029 (US$M) |
| Figure 10‑3: Peripherally Inserted Central Catheter Market by Valve Type, U.S., 2019 – 2029 (US$M) |
| Figure 10‑4: Peripherally Inserted Central Catheter Market by Kit Type, U.S., 2019 – 2029 (US$M) |
| Figure 10‑5: Total Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑6: Tip-Placement Peripherally Inserted Central Catheter Kit Market by Lumen Number, U.S., 2019 – 2029 (US$M) |
| Figure 10‑7: Tip-Placement Peripherally Inserted Central Catheter Kit Market, U.S., 2019 – 2029 |
| Figure 10‑8: Single-Lumen Tip-Placement Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑9: Double-Lumen Tip-Placement Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑10: Triple-Lumen Tip-Placement Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑11: Peripherally Inserted Central Catheter Market by Type, U.S., 2019 – 2029 (US$M) |
| Figure 10‑12: Tip-Placement Peripherally Inserted Central Catheter Kit Market, U.S., 2019 – 2029 |
| Figure 10‑13: Non-Power-Injectable Tip-Placement Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑14: Power-Injectable Tip-Placement Peripherally Inserted Central Catheter Market by Type, U.S., 2019 – 2029 (US$M) |
| Figure 10‑15: Power-Injectable Tip-Placement Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑16: Antimicrobial Power-Injectable Tip-Placement Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑17: Conventional Power-Injectable Tip-Placement Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑18: Basic Peripherally Inserted Central Catheter Kit Market by Lumen Number, U.S., 2019 – 2029 (US$M) |
| Figure 10‑19: Basic Peripherally Inserted Central Catheter Kit Market, U.S., 2019 – 2029 |
| Figure 10‑20: Single-Lumen Basic Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑21: Double-Lumen Basic Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑22: Triple-Lumen Basic Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑23: Basic Peripherally Inserted Central Catheter Market by Type, U.S., 2019 – 2029 (US$M) |
| Figure 10‑24: Basic Peripherally Inserted Central Catheter Kit Market, U.S., 2019 – 2029 |
| Figure 10‑25: Non-Power-Injectable Basic Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑26: Power-Injectable Basic Peripherally Inserted Central Catheter Market by Type, U.S., 2019 – 2029 (US$M) |
| Figure 10‑27: Power-Injectable Basic Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑28: Antimicrobial Power-Injectable Basic Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑29: Antithrombogenic Power-Injectable Basic Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑30: Conventional Power-Injectable Basic Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑31: Hospital-Based Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑32: Non-Hospital-Based Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑33: Valved Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑34: Non-Valved Peripherally Inserted Central Catheter Market, U.S., 2019 – 2029 |
| Figure 10‑35: Long Guidewire Peripherally Inserted Central Catheter Kit Market, U.S., 2019 – 2029 |
| Figure 10‑36: Standard Peripherally Inserted Central Catheter Kit Market, U.S., 2019 – 2029 |
| Figure 10‑37: Peripherally Inserted Central Catheter Units Sold by Material, U.S., 2019 – 2029 |
| Figure 10‑38: Peripherally Inserted Central Catheter Units Sold by Material and Lumen, U.S., 2022 |
| Figure 10‑39: Peripherally Inserted Central Catheter Units Sold by Age and Material, U.S., 2022 |
| Figure 10‑40: Leading Competitors, Peripherally Inserted Central Catheter Market, U.S., 2022 |
| Figure 11‑1: Peripheral Intravenous Catheter Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 11‑2: Peripheral Intravenous Catheter Market by Setting, U.S., 2019 – 2029 (US$M) |
| Figure 11‑3: Total Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
| Figure 11‑4: Conventional Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
| Figure 11‑5: Safety Peripheral Intravenous Catheter Market by Type, U.S., 2019 – 2029 (US$M) |
| Figure 11‑6: Safety Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
| Figure 11‑7: Blood Control Safety Peripheral Intravenous Catheter Market by Type, U.S., 2019 – 2029 (US$M) |
| Figure 11‑8: Blood Control Safety Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
| Figure 11‑9: Integrated Blood Control Safety Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
| Figure 11‑10: Non-Integrated Blood Control Safety Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
| Figure 11‑11: Non-Blood Control Safety Peripheral Intravenous Catheter Market by Type, U.S., 2019 – 2029 (US$M) |
| Figure 11‑12: Non-Blood Control Safety Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
| Figure 11‑13: Non-Blood Control Active Safety Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
| Figure 11‑14: Non-Blood Control Passive Safety Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
| Figure 11‑15: Acute Care Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
| Figure 11‑16: Alternate Care Peripheral Intravenous Catheter Market by Setting, U.S., 2019 – 2029 (US$M) |
| Figure 11‑17: Alternate Care Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
| Figure 11‑18: Home Care Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
| Figure 11‑19: Outpatient and Nursing Home Care Peripheral Intravenous Catheter Market, U.S., 2019 – 2029 |
| Figure 11‑20: Peripheral Intravenous Catheter Units Sold by Length, U.S., 2019 – 2029 |
| Figure 11‑21: Peripheral Intravenous Catheter Units Sold by Insertion Site, U.S., 2019 – 2029 |
| Figure 11‑22: Peripheral Intravenous Catheter Units Sold by Insertion Technique, U.S., 2019 – 2029 |
| Figure 11‑23: Leading Competitors, Peripheral Intravenous Catheter Market, U.S., 2019 |
| Figure 12‑1: Midline Market by Insertion Method, U.S., 2019 – 2029 (US$M) |
| Figure 12‑2: Midline Market, U.S., 2019 – 2029 |
| Figure 12‑3: AST Midline Market, U.S., 2019 – 2029 |
| Figure 12‑4: MST Midline Market by Power Injectability, U.S., 2019 – 2029 |
| Figure 12‑5: MST Midline Market, U.S., 2019 – 2029 |
| Figure 12‑6: MST Midline Market by Power Injectability, U.S., 2019 – 2029 |
| Figure 12‑7: Total Power-Injectable MST Midline Market, U.S., 2019 – 2029 |
| Figure 12‑8: Long Power-Injectable MST Midline Market, U.S., 2019 – 2029 |
| Figure 12‑9: Short Power-Injectable MST Midline Market, U.S., 2019 – 2029 |
| Figure 12‑10: Non-Power-Injectable MST Midline Market, U.S., 2019 – 2029 |
| Figure 12‑11: Leading Competitors, Midline Market, U.S., 2022 |
| Figure 13‑1: Extended Dwell Catheter Market, U.S., 2019 – 2029 |
| Figure 13‑2: Leading Competitors, Extended Dwell Catheter Market, U.S., 2022 |
| Figure 14‑1: Dialysis Catheter Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 14‑2: Dialysis Catheter Market, U.S., 2019 – 2029 |
| Figure 14‑3: Hemodialysis Catheter Market by Dwell Time, U.S., 2019 – 2029 (US$M) |
| Figure 14‑4: Total Hemodialysis Catheter Market, U.S., 2019 – 2029 |
| Figure 14‑5: Long-Term Hemodialysis Catheter Market by Device Type, U.S., 2019 – 2029 (US$M) |
| Figure 14‑6: Total Long-Term Hemodialysis Catheter Market, U.S., 2019 – 2029 |
| Figure 14‑7: Conventional Long-Term Hemodialysis Catheter Market, U.S., 2019 – 2029 |
| Figure 14‑8: Advanced Material Long-Term Hemodialysis Catheter Market, U.S., 2019 – 2029 |
| Figure 14‑9: Long-Term Hemodialysis Catheter Market by Care Setting, U.S., 2019 – 2029 (US$M) |
| Figure 14‑10: In Center Long-Term Hemodialysis Catheter Market, U.S., 2019 – 2029 |
| Figure 14‑11: Home Care Long-Term Hemodialysis Catheter Market, U.S., 2019 – 2029 |
| Figure 14‑12: Short-Term Hemodialysis Catheter Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 14‑13: Total Short-Term Hemodialysis Catheter Market, U.S., 2019 – 2029 |
| Figure 14‑14: Power-Injectable Short-Term Hemodialysis Catheter Market, U.S., 2019 – 2029 |
| Figure 14‑15: Non-Power-Injectable Short-Term Hemodialysis Catheter Market, U.S., 2019 – 2029 |
| Figure 14‑16: Peritoneal Dialysis Catheter Market, U.S., 2019 – 2029 |
| Figure 14‑17: Leading Competitors, Dialysis Catheter Market, U.S., 2022 |
| Figure 15‑1: Ultrasound Vascular Access Device and Accessory Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 15‑2: Cart-Based Ultrasound System Specialized for Vascular Access Market, U.S., 2019 – 2029 |
| Figure 15‑3: Hand-Carried and Portable Ultrasound System Specialized for Vascular Access Market, U.S., 2019 – 2029 |
| Figure 15‑4: Leading Competitors, Ultrasound Vascular Access Device and Accessory Market, U.S., 2022 |
| Figure 16‑1: Vein Visualization Technology Market, U.S., 2019 – 2029 |
| Figure 16‑2: Leading Competitors, Vein Visualization Technology Market, U.S., 2022 |
| Figure 17‑1: Tip-Placement System and Accessory Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 17‑2: Tip-Placement System Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 17‑3: Total Tip-Placement System Market, U.S., 2019 – 2029 |
| Figure 17‑4: Standalone Tip-Placement System Market, U.S., 2019 – 2029 |
| Figure 17‑5: Integrated Tip-Placement System Market, U.S., 2019 – 2029 |
| Figure 17‑6: Disposable Tip-Placement Accessory Market, U.S., 2019 – 2029 |
| Figure 17‑7: Leading Competitors, Tip-Placement System and Accessory Market, U.S., 2022 |
| Figure 18‑1: Catheter Securement Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 18‑2: Catheter Securement Market, U.S., 2019 – 2029 |
| Figure 18‑3: Tape and Dressing Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 18‑4: Total Tape and Dressing Market, U.S., 2019 – 2029 |
| Figure 18‑5: Antimicrobial Tape and Dressing Market, U.S., 2019 – 2029 |
| Figure 18‑6: Standard Tape and Dressing Market, U.S., 2019 – 2029 |
| Figure 18‑7: Suture Market, U.S., 2019 – 2029 |
| Figure 18‑8: Manufactured Catheter Securement Device Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 18‑9: Total Manufactured Catheter Securement Device Market, U.S., 2019 – 2029 |
| Figure 18‑10: Mechanical Manufactured Catheter Securement Device Market, U.S., 2019 – 2029 |
| Figure 18‑11: Non-Mechanical Manufactured Catheter Securement Device Market, U.S., 2019 – 2029 |
| Figure 18‑12: Manufactured Catheter Securement Device Units Sold by Catheter Type, U.S., 2019 – 2029 |
| Figure 18‑13: Leading Competitors, Catheter Securement Market, U.S., 2022 |
| Figure 19‑1: Antibacterial Catheter Patch Market, U.S., 2019 – 2029 |
| Figure 19‑2: Leading Competitors, Antibacterial Catheter Patch Market, U.S., 2022 |
| Figure 20‑1: Catheter Cap Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 20‑2: Catheter Cap Market, U.S., 2019 – 2029 |
| Figure 20‑3: Standard Catheter Cap Market, U.S., 2019 – 2029 |
| Figure 20‑4: Dialysis Catheter Cap Market, U.S., 2019 – 2029 |
| Figure 20‑5: Leading Competitors, Catheter Cap Market, U.S., 2022 |
| Figure 21‑1: Syringe and Needle Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 21‑2: Syringe Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 21‑3: Total Syringe Market, U.S., 2019 – 2029 |
| Figure 21‑4: Conventional Syringe Market, U.S., 2019 – 2029 |
| Figure 21‑5: Sliding Sleeve Safety Syringe Market, U.S., 2019 – 2029 |
| Figure 21‑6: Retractable Safety Syringe Market, U.S., 2019 – 2029 |
| Figure 21‑7: Hinged Safety Syringe Market, U.S., 2019 – 2029 |
| Figure 21‑8: Insulin Syringe Market by Usage, U.S., 2019 – 2029 (US$M) |
| Figure 21‑9: Total Insulin Syringe Market, U.S., 2019 – 2029 |
| Figure 21‑10: Personal Insulin Syringe Market, U.S., 2019 – 2029 |
| Figure 21‑11: Professional Insulin Syringe Market, U.S., 2019 – 2029 |
| Figure 21‑12: Insulin Syringe Market by Device Type, U.S., 2019 – 2029 (US$M) |
| Figure 21‑13: Total Insulin Syringe Market, U.S., 2019 – 2029 |
| Figure 21‑14: Safety Insulin Syringe Market, U.S., 2019 – 2029 |
| Figure 21‑15: Non-Safety Insulin Syringe Market, U.S., 2019 – 2029 |
| Figure 21‑16: Needle Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 21‑17: Total Needle Market, U.S., 2019 – 2029 |
| Figure 21‑18: Conventional Needle Market, U.S., 2019 – 2029 |
| Figure 21‑19: Shielding Safety Needle Market, U.S., 2019 – 2029 |
| Figure 21‑20: Pivoting Needle Market, U.S., 2019 – 2029 |
| Figure 21‑21: Blunt Fill Needle Market, U.S., 2019 – 2029 |
| Figure 21‑22: Insulin Pen Needle Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 21‑23: Total Insulin Pen Needle Market, U.S., 2019 – 2029 |
| Figure 21‑24: Safety Insulin Pen Needle Market, U.S., 2019 – 2029 |
| Figure 21‑25: Non-Safety Insulin Pen Needle Market, U.S., 2019 – 2029 |
| Figure 21‑26: Leading Competitors, Syringe and Needle Market, U.S., 2022 |
| Figure 22‑1: Multi-Purpose Hand-Carried and Portable Ultrasound System Market, U.S., 2019 – 2029 |
| Figure 22‑2: Leading Competitors, Multi-Purpose Hand-Carried and Portable Ultrasound Market, U.S., 2022 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Vascular Access Devices Market Size, Share & COVID-19 Impact Analysis | United States | 2023-2029 | MedSuite | Includes: Implantable Ports, Port Needles, Central Venous Catheters, and 12 more
$7,995 – $9,995
iData’s U.S. vascular access MedSuite covers 15 markets including implantable ports, needles, and syringes. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.
- 2023
- 10 Years
- United States
- 03/07/2023
- 666
- MedSuite
Related Reports
